Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 24, 2026 06:45 ET | Source: BioNTech SE

BioNTech auf dem ELCC-Kongress 2026: Neue klinische Daten unterstreichen das Potenzial des differenzierten, spätklinischen Portfolios bei Lungenkrebs

Präsentationen zeigen Fortschritte in BioNTechs spätklinischen Programmen im Bereich Lungenkrebs und unterstreichen das Potenzial des differenzierten Unternehmensportfolios, welches Immunmodulatoren,...
March 24, 2026 06:45 ET | Source: BioNTech SE

BioNTech Clinical Data at ELCC 2026 Highlight Potential of Differentiated Late-Stage Portfolio in Lung Cancer

Presentations showcase progress in BioNTech’s late-stage lung cancer programs, reinforcing the potential of the Company’s differentiated portfolio spanning immunomodulators, antibody-drug conjugates,...
March 17, 2026 08:08 ET | Source: Liminatus Pharma Inc.

Liminatus Pharma Announces Planned Phase 1 Clinical Trial of IBA101, a Next-Generation CD47 Blocking Antibody

Liminatus announces plan to initiate a Phase 1 clinical trial evaluating IBA101, a next-generation CD47-blocking monoclonal antibody.
March 11, 2026 08:00 ET | Source: Noah Medical

Respiratory Medicine Publishes MATCH 2 Study Demonstrating Reliability of Real-Time Imaging Guidance in Robotic Bronchoscopy

Noah Medical today announced the publication of the MATCH 2 study in the international, peer-reviewed journal, Respiratory Medicine.
March 02, 2026 04:04 ET | Source: Research and Markets

Monoclonal Antibodies (mAbs) for Oncology Global Report 2026: A $228 Billion Market by 2030, Driven by Technological Advances, New Product Launches, Label Expansions, Increasing Prevalence

Dublin, March 02, 2026 (GLOBE NEWSWIRE) -- The "Monoclonal Antibodies for Oncology: Global Markets" report has been added to ResearchAndMarkets.com's offering.The global market for monoclonal...
February 04, 2026 07:30 ET | Source: Lung Health Foundation

‘Think Mortgage Calculator, But for Lung Cancer Risk’: A More User-Friendly Self-Serve Tool Gives Canadians and Healthcare Providers a Clearer Starting Point

A simple online tool offered by Lung Health Foundation helps people understand their potential lung cancer risk.
January 19, 2026 06:41 ET | Source: Research and Markets

Cancer Cachexia Market Poised to Reach USD 3.90 Billion by 2033

Dublin, Jan. 19, 2026 (GLOBE NEWSWIRE) -- The "Cancer Cachexia Market Size, Share & Trends Analysis Report by Treatment (Appetite Stimulants, Corticosteroids), Type (Lung Cancer, Colorectal...
January 14, 2026 08:38 ET | Source: Research and Markets

$105+ Bn Non-Small Cell Lung Cancer (NSCLC) Global Market Trends, Strategies, and Opportunities, 2019-2024, 2024-2029F, 2034F

Dublin, Jan. 14, 2026 (GLOBE NEWSWIRE) -- The "Non-Small Cell Lung Cancer (NSCLC) Global Market Opportunities and Strategies to 2034" has been added to ResearchAndMarkets.com's offering. The...
December 02, 2025 10:04 ET | Source: Research and Markets

Interventional Oncology Devices Research Report 2025 - Global Market Size, Share, Trends, Opportunities, and Forecasts, 2020-2030F

Dublin, Dec. 02, 2025 (GLOBE NEWSWIRE) -- The "Interventional Oncology Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...
November 27, 2025 08:24 ET | Source: Research and Markets

EpCAM-Targeted Immunotherapies Pipeline and Competitive Intelligence Report 2025

Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Pipeline of EpCAM-Targeted Immunotherapies" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report about...